Sabra Health Care REIT, Inc. — fact timeline

Sabra Health Care REIT, Inc. shareholders approved Advisory Compensation Vote at the 2026-06-17 meeting.

“Advisory Compensation Vote For Against Abstain Broker Non-Votes 199,568,777 7,867,562 355,123 20,607,679”

Sabra Health Care REIT, Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2026-06-17 meeting.

“Auditor Ratification For Against Abstain Broker Non-Votes 226,576,585 1,648,639 173,917 —”

Sabra Health Care REIT, Inc. shareholders approved Election of Directors at the 2026-06-17 meeting.

“Election of Directors For Against Abstain Broker Non-Votes Craig A. Barbarosh 203,295,021 4,352,019 144,422 20,607,679 Katie Cusack 205,669,611 1,508,172 613,679 20,607,679 Michael J. Foster 201,703,451 5,940,779 147,232 20,607,679 Lynne S. Katzmann 202,722,219 4,938,575 130,668 20,607,679 Ann Kono 205,652,052 1,521,149 618,261 20,607,679 Jeffrey A. Malehorn 206,395,107 1,254,574 141,781 20,607,679 Richard K. Matros 201,695,777 5,948,753 146,932 20,607,679”

Sabra Health Care REIT, Inc. reported first quarter of 2026 results: EPS $0.16. Guidance reaffirmed.

“Results per diluted common share for the first quarter of 2026 were as follows: • Net Income: $0.16”

Sabra Health Care REIT, Inc. incurred term loan of $500.0 million U.S. dollar term loan with KeyBank National Association as Administrative Agent and the lenders at ratings-based applicable interest margin plus, at the Operating Partnership’s op maturing July 30, 2030.

“The Term Loan Credit Agreement includes a $500.0 million U.S. dollar term loan (the “Term Loan”). The Term Loan Credit Agreement also contains an accordion feature that can increase the total available borrowings to $1.0 billion, subject to terms and conditions. The Term Loan has a maturity date of July 30, 2030. The Term Loan bears interest on the outstanding principal amount at a ratings-based applicable interest margin plus, at the Operating Partnership’s option, either (a) Daily SOFR, (b) Term SOFR or (c) the Base Rate, each as defined in the Term Loan Credit Agreement. The ratings-based applicable interest margin for borrowings will vary based on the Debt Ratings, as defined in the Term Loan Credit Agreement, and will range from 0.800% to 1.600% per annum for SOFR-based borrowings and 0.000% to 0.600% per annum for borrowings at the Base Rate.”

Darrin Smith was appointed as Chief Investment Officer at Sabra Health Care REIT, Inc..

“Darrin Smith, Sabra’s Executive Vice President – Investments, is expected to assume this position effective January 1, 2026.”

Talya Nevo-Hacohen retired as Executive Vice President, Chief Investment Officer and Treasurer at Sabra Health Care REIT, Inc..

“Talya Nevo-Hacohen, the Company’s Executive Vice President, Chief Investment Officer and Treasurer, has decided to retire from Sabra, effective December 31, 2025”

Clifton J. Porter II departed as Director at Sabra Health Care REIT, Inc..

“On November 7, 2024, Clifton J. Porter II notified the Board of Directors of Sabra Health Care REIT, Inc. (the “Company”) of his decision not to stand for reelection to the Company’s Board of Directors at the Company’s 2025 annual meeting of shareholders.”

Sabra Health Care REIT, Inc. updated its the three month period ended March 31, 2024 guidance (reaffirmed).

“On May 8, 2024, Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended March 31, 2024.”

Sabra Health Care REIT, Inc. reported the fourth quarter of 2023 results: net income $0.07. Guidance initiated.

“Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2023. FOURTH QUARTER 2023 RESULTS AND RECENT EVENTS • Results per diluted common share for the fourth quarter of 2023 were as follows: • Net Income: $0.07”

Jessica Flores was appointed as Executive Vice President and Chief Accounting Officer at Sabra Health Care REIT, Inc..

“On and effective as of January 1, 2024, the Board of Directors of Sabra Health Care REIT, Inc., a Maryland corporation (“Sabra” or the “Company”), appointed Jessica Flores to serve as Executive Vice President and Chief Accounting Officer until her successor is duly elected and qualifies.”

Sabra Health Care REIT, Inc. reported financial results for the three month period ended September 30, 2023.

“On November 6, 2023, Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended September 30, 2023.”

Sabra Health Care REIT, Inc. reported the second quarter of 2023 results: net income $0.09, EPS $0.09.

“Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended June 30, 2023.”

Sabra Health Care REIT, Inc. shareholders approved Advisory vote on frequency of future advisory votes on named executive officer compensation at the 2023-06-14 meeting.

“approved, on an advisory basis, a one-year frequency for future advisory votes on named executive officer compensation (“Advisory Frequency Vote”)”

Sabra Health Care REIT, Inc. shareholders approved Advisory vote on compensation of named executive officers at the 2023-06-14 meeting.

“approved, on an advisory basis, the compensation of the Company’s named executive officers as set forth in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 24, 2023 (“Advisory Compensation Vote”)”

Sabra Health Care REIT, Inc. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-14 meeting.

“ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 (“Auditor Ratification”)”

Sabra Health Care REIT, Inc. shareholders approved Election of Directors at the 2023-06-14 meeting.

“elected the eight nominees identified in the table below to the Board of Directors of the Company to serve until the Company’s 2024 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified (“Election of Directors”)”

Sabra Health Care REIT, Inc. reported first quarter of 2023 results: net income Net Loss: $(0.04), EPS Net Loss: $(0.04).

“Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended March 31, 2023.”

Sabra Health Care REIT, Inc. reported financial results for the fourth quarter of 2022.

“On February 21, 2023, Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended December 31, 2022.”

Sabra Health Care REIT, Inc. amended term loan of CAD $150.0 million Canadian dollar term loan with Bank of America, N.A. at The Canadian dollar Term Loan bears interest on the outstanding principal amount maturing January 4, 2028.

“the Credit Agreement. The Credit Agreement includes a $1.0 billion revolving credit facility (the “Revolving Credit Facility”), a $430.0 million U.S. dollar term loan and a CAD $150.0 million Canadian dollar term loan (collectively, the “Term Loans”). The Prior Credit Agreement included a $1.0 billion revolving credit facility, $1.1 billion in U.S. dollar term loans”

Sabra Health Care REIT, Inc. amended term loan of $430.0 million U.S. dollar term loan with Bank of America, N.A. at The ratings-based applicable interest margin for borrowings will vary based on t maturing January 4, 2028.

“have the meanings set forth for such terms in the Credit Agreement. The Credit Agreement includes a $1.0 billion revolving credit facility (the “Revolving Credit Facility”), a $430.0 million U.S. dollar term loan and a CAD $150.0 million Canadian dollar term loan (collectively, the “Term Loans”). The Prior Credit Agreement included a $1.0 billion revolving credit”

Sabra Health Care REIT, Inc. amended revolving credit of $1.0 billion revolving credit facility with Bank of America, N.A. at Borrowings under the Revolving Credit Facility bear interest on the outstanding maturing January 4, 2027.

“September 9, 2019. Capitalized terms used but not defined in this Item 1.01 have the meanings set forth for such terms in the Credit Agreement. The Credit Agreement includes a $1.0 billion revolving credit facility (the “Revolving Credit Facility”), a $430.0 million U.S. dollar term loan and a CAD $150.0 million Canadian dollar term loan (collectively, the “Term”

Sabra Health Care REIT, Inc. amended Credit Agreement with certain lenders and agents valued at $1.0 billion revolving credit facility, a $430.0 million U.S. dollar term loan and a CAD $150.0 mill (effective 2023-01-04).

“On January 4, 2023, Sabra Health Care Limited Partnership, of which Sabra Health Care REIT, Inc. (“Sabra”) is the sole general partner (the “Operating Partnership”), and Sabra Canadian Holdings, LLC, also a wholly owned subsidiary of Sabra (together, the “Borrowers”), and the other parties thereto entered into a sixth amended and restated unsecured credit agreement (the “Credit Agreement”) with certain lenders as set forth therein; Bank of America, N.A., as Administrative Agent and L/C Issuer; Citizens Bank, National Association, Crédit Agricole Corporate and Investment Bank and Wells Fargo Bank, National Association, as Co-Syndication Agents and L/C Issuers; The Bank of Nova Scotia, Fifth Third Bank, JPMorgan Chase Bank, N.A., Keybank National Association, Mizuho Bank, Ltd., and Truist Bank, as Co-Documentation Agents; BofA Securities, Inc., as Joint Lead Arranger and Sole Bookrunner; and Citizens Bank, National Association, Crédit Agricole Corporate and Investment Bank and Wells Farg”

Sabra Health Care REIT, Inc.: Filed Articles Supplementary prohibiting election to be subject to Section 3-803 of MGCL (classifying board) without stockholder approval (effective 2022-12-16).

“On December 16, 2022, the Company filed Articles Supplementary with the State Department of Assessments and Taxation of Maryland reflecting the adoption of this resolution.”

Sabra Health Care REIT, Inc.: Amended and restated bylaws to update universal proxy rules, advance notice provisions, and other conforming changes (effective 2022-12-15).

“In addition, on December 15, 2022, the Board approved an amendment and restatement of the Company’s Amended and Restated Bylaws (as so amended and restated, the “Bylaws”) to update various provisions of the Bylaws to require parties proposing a nominee for election of a director to comply with the universal proxy rules recently adopted by the U.S. Securities and Exchange Commission.”

Sabra Health Care REIT, Inc. terminated Distribution Agreement (effective 2022-11-09).

“On November 9, 2022, Sabra Health Care REIT, Inc. (“Sabra”) terminated that certain equity distribution agreement entered into on August 6, 2021 among Sabra and the sales agents and forward purchasers party thereto (the “Distribution Agreement”).”

Sabra Health Care REIT, Inc. reported third quarter of 2022 results: net income Net Loss: $(0.22), EPS $(0.22) per diluted common share.

“Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended September 30, 2022.”

Raymond J. Lewis resigned as Director at Sabra Health Care REIT, Inc..

“On February 7, 2022, Raymond J. Lewis notified the Board of Directors of Sabra Health Care REIT, Inc. (the “Company”) of his resignation from the Company’s Board of Directors, effective immediately.”

Ronald G. Geary resigned as Director at Sabra Health Care REIT, Inc..

“On January 24, 2022, Ronald G. Geary notified the Board of Directors of Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) of his resignation from Sabra’s Board of Directors, effective immediately.”

Michael Costa was appointed as Executive Vice President, Chief Financial Officer (Principal Financial Officer) and Secretary at Sabra Health Care REIT, Inc..

“On December 30, 2021, Sabra’s Board of Directors appointed Michael Costa, Sabra’s Executive Vice President – Finance and Chief Accounting Officer (Principal Accounting Officer), to succeed Mr. Andrews as the Company’s Executive Vice President, Chief Financial Officer (Principal Financial Officer) and Secretary, in each case effective January 1, 2022.”

Harold Andrews retired as Executive Vice President, Chief Financial Officer (Principal Financial Officer) and Secretary at Sabra Health Care REIT, Inc..

“Harold Andrews, the Company’s Executive Vice President, Chief Financial Officer (Principal Financial Officer) and Secretary, retired from Sabra effective December 31, 2021.”

Michael Costa was appointed as Executive Vice President, Chief Financial Officer (Principal Financial Officer) and Secretary at Sabra Health Care REIT, Inc..

“Michael Costa, Sabra’s Executive Vice President – Finance and Chief Accounting Officer, is expected to assume each of these positions effective January 1, 2022.”

Harold Andrews retired as Executive Vice President, Chief Financial Officer (Principal Financial Officer) and Secretary at Sabra Health Care REIT, Inc..

“Harold Andrews, the Company’s Executive Vice President, Chief Financial Officer (Principal Financial Officer) and Secretary, has decided to retire from Sabra, effective December 31, 2021”